This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine
March 29, 2021 at 10:29 AM EDT
Hannu Rajaniemi, the co-founder and CEO of Helix Nanotechnologies, has spent the last year racing to come up with a mutation-resistant Covid-19 vaccine.
